{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:32:40Z","timestamp":1793424760837,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["LHGJ20220938"],"award-info":[{"award-number":["LHGJ20220938"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Provincial Key Clinical Specialty"},{"name":"Luoyang Municipal Medical and Health General Project","award":["2022022Y"],"award-info":[{"award-number":["2022022Y"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10067-026-08406-2","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:30:41Z","timestamp":1788881441000},"page":"7061-7068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autologous hematopoietic stem cell transplantation in a patient with rheumatoid arthritis and multiple myeloma: a case-based narrative literature review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2000-378X","authenticated-orcid":false,"given":"Wenyi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8141-5663","authenticated-orcid":false,"given":"Shuli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"2","key":"8406_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00277-018-3515-2","volume":"98","author":"S Hu","year":"2019","unstructured":"Hu S, Zhou D, Wu Y et al (2019) Autoimmune disease-associated non-Hodgkin\u2019s lymphoma-a large retrospective study from China. Ann Hematol 98(2):445\u2013455. https:\/\/doi.org\/10.1007\/s00277-018-3515-2","journal-title":"Ann Hematol"},{"issue":"1","key":"8406_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01327-x","volume":"24","author":"P Jin","year":"2024","unstructured":"Jin P, Jin X, He L et al (2024) The casual relationship between autoimmune diseases and multiple myeloma: a Mendelian randomization study. Clin Exp Med 24(1):65. https:\/\/doi.org\/10.1007\/s10238-024-01327-x","journal-title":"Clin Exp Med"},{"issue":"3","key":"8406_CR3","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s12032-011-0022-x","volume":"29","author":"N Suvajdzic","year":"2012","unstructured":"Suvajdzic N, Djurdjevic P, Todorovic M et al (2012) Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases. Med Oncol 29(3):2207\u20132211. https:\/\/doi.org\/10.1007\/s12032-011-0022-x","journal-title":"Med Oncol"},{"issue":"12","key":"8406_CR4","doi-asserted-by":"publisher","first-page":"103918","DOI":"10.1016\/j.autrev.2025.103918","volume":"24","author":"Y Yan","year":"2025","unstructured":"Yan Y, Sun C, Hoang MH et al (2025) Hedgehog signaling pathway: a research review on a new therapeutic target for rheumatoid arthritis[J]. Autoimmun Rev 24(12):103918. https:\/\/doi.org\/10.1016\/j.autrev.2025.103918","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8406_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1542\/peds.2008-1871","volume":"32","author":"AL Franks","year":"2012","unstructured":"Franks AL, Slansky JE (2012) Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer[J]. Anticancer Res 32(4):1119\u20131136. https:\/\/doi.org\/10.1542\/peds.2008-1871","journal-title":"Anticancer Res"},{"issue":"6","key":"8406_CR6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/s0049-0172(97)80023-6","volume":"26","author":"L Georgescu","year":"1997","unstructured":"Georgescu L, Quinn GC, Schwartzman S et al (1997) Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment[J]. Semin Arthritis Rheum 26(6):794\u2013804. https:\/\/doi.org\/10.1016\/s0049-0172(97)80023-6","journal-title":"Semin Arthritis Rheum"},{"key":"8406_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.70086","author":"SJ Quinn","year":"2026","unstructured":"Quinn SJ, Cardwell C, Anderson LA et al (2026) Rate of MGUS progression to haematological malignancies: a systematic review. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.70086","journal-title":"Eur J Haematol"},{"issue":"6","key":"8406_CR8","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1182\/bloodadvances.2020003193","volume":"5","author":"N Steiner","year":"2021","unstructured":"Steiner N, G\u00f6bel G, Michaeler D et al (2021) Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma[J]. Blood Adv 5(6):1746\u20131754. https:\/\/doi.org\/10.1182\/bloodadvances.2020003193","journal-title":"Blood Adv"},{"issue":"24","key":"8406_CR9","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","volume":"118","author":"EK Lindqvist","year":"2011","unstructured":"Lindqvist EK, Goldin LR, Landgren O et al (2011) Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study[J]. Blood 118(24):6284\u20136291. https:\/\/doi.org\/10.1182\/blood-2011-04-347559","journal-title":"Blood"},{"issue":"6","key":"8406_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/BF02207669","volume":"18","author":"EL Matteson","year":"1991","unstructured":"Matteson EL, Hickey AR, Maguire L et al (1991) Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. Rheumatoid arthritis azathioprine registry steering committee[J]. J Rheumatol 18(6):809\u2013814. https:\/\/doi.org\/10.1007\/BF02207669","journal-title":"J Rheumatol"},{"issue":"4","key":"8406_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjh.17824","volume":"195","author":"D Kaji","year":"2021","unstructured":"Kaji D, Kusakabe M, Sakata-Yanagimoto M et al (2021) Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases[J]. British J Haematol 195(4):585\u2013594. https:\/\/doi.org\/10.1111\/bjh.17824","journal-title":"British J Haematol"},{"issue":"2","key":"8406_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.rhu.0000255805.15227.92","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu J, Fujita S et al (2007) Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication[J]. J Rheumatol 34(2):322\u2013331. https:\/\/doi.org\/10.1097\/01.rhu.0000255805.15227.92","journal-title":"J Rheumatol"},{"issue":"1","key":"8406_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-025-00457-3","volume":"9","author":"K Tokareva","year":"2025","unstructured":"Tokareva K, Peterson AC, Baraff A et al (2025) Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US veterans with rheumatoid arthritis. BMC Rheumatol 9(1):7. https:\/\/doi.org\/10.1186\/s41927-025-00457-3","journal-title":"BMC Rheumatol"},{"key":"8406_CR14","doi-asserted-by":"publisher","first-page":"1827981","DOI":"10.3389\/fimmu.2026.1827981","volume":"17","author":"S Li","year":"2026","unstructured":"Li S, Zou Y, Li J et al (2026) Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides[J]. Front Immunol 17:1827981. https:\/\/doi.org\/10.3389\/fimmu.2026.1827981","journal-title":"Front Immunol"},{"issue":"7","key":"8406_CR15","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.3390\/ijms26072943","volume":"26","author":"O Tarj\u00e1nyi","year":"2025","unstructured":"Tarj\u00e1nyi O, Olasz K, R\u00e1tky F et al (2025) Proteasome inhibitors: potential in rheumatoid arthritis therapy?[J]. Int J Mol Sci 26(7):2943. https:\/\/doi.org\/10.3390\/ijms26072943","journal-title":"Int J Mol Sci"},{"issue":"11","key":"8406_CR16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1136\/ard.2008.097709","volume":"68","author":"S Lee","year":"2009","unstructured":"Lee S, Kim J, Park Y et al (2009) Bortezomib attenuates murine collagen-induced arthritis[J]. Ann Rheum Dis 68(11):1761\u20131767. https:\/\/doi.org\/10.1136\/ard.2008.097709","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8406_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.chemosphere.2006.12.045","volume":"27","author":"JW van der Heijden","year":"2009","unstructured":"van der Heijden JW, Oerlemans R, Lems WF et al (2009) The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients[J]. Clin Exp Rheumatol 27(1):92\u201398. https:\/\/doi.org\/10.1016\/j.chemosphere.2006.12.045","journal-title":"Clin Exp Rheumatol"},{"issue":"52","key":"8406_CR18","doi-asserted-by":"publisher","first-page":"e5760","DOI":"10.1097\/MD.0000000000005760","volume":"95","author":"J Liu","year":"2016","unstructured":"Liu J, Li J, Chen M et al (2016) Bortezomib followed by autologous stem cell transplantation in a patient with rheumatoid arthritis: a case report and review of the literature[J]. Medicine 95(52):e5760. https:\/\/doi.org\/10.1097\/MD.0000000000005760","journal-title":"Medicine"},{"issue":"1","key":"8406_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2169\/internalmedicine.4235-24","volume":"65","author":"K Ikegame","year":"2026","unstructured":"Ikegame K (2026) CAR-T therapy can be a useful treatment modality for more than just hematologic malignancies. Int Med (Tokyo, Japan) 65(1):32\u201340. https:\/\/doi.org\/10.2169\/internalmedicine.4235-24","journal-title":"Int Med (Tokyo, Japan)"},{"issue":"1","key":"8406_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tips.2025.11.001","volume":"47","author":"Y Li","year":"2026","unstructured":"Li Y, Yang L (2026) Autologous, allogeneic, in vivo CAR for autoimmune diseases[J]. Trends Pharmacol Sci 47(1):11\u201314. https:\/\/doi.org\/10.1016\/j.tips.2025.11.001","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"8406_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27020909","volume":"27","author":"M Sioud","year":"2026","unstructured":"Sioud M, Casey NP (2026) Engineering immunity: current progress and future directions of CAR-T cell therapy. Int J Mol Sci 27(2):909. https:\/\/doi.org\/10.3390\/ijms27020909","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8406_CR22","doi-asserted-by":"publisher","first-page":"e6417","DOI":"10.1136\/rmdopen-2025-006417","volume":"12","author":"A Santosa","year":"2026","unstructured":"Santosa A, Tan TC (2026) CAR-T cell therapy for treatment-refractory rheumatic autoimmune diseases: a systematic review of clinical outcomes and safety profiles[J]. RMD Open 12(1):e6417. https:\/\/doi.org\/10.1136\/rmdopen-2025-006417","journal-title":"RMD Open"},{"key":"8406_CR23","doi-asserted-by":"publisher","first-page":"103164","DOI":"10.1016\/j.tice.2025.103164","volume":"98","author":"MM HojatiShargh","year":"2026","unstructured":"HojatiShargh MM, Mahmoudi M, Agah SAA et al (2026) CAR T-cell therapy in autoimmune diseases: opportunities and challenges, with implications for RA[J]. Tissue Cell 98:103164. https:\/\/doi.org\/10.1016\/j.tice.2025.103164","journal-title":"Tissue Cell"},{"key":"8406_CR24","doi-asserted-by":"publisher","unstructured":"Paruzzo L, Bouvier R, Fulmer B (2025) Chimeric antigen receptor T-cell therapy in patients with coexisting malignancy and autoimmune disease[J]. Blood 4543(146(Supplement 1)):4543. https:\/\/doi.org\/10.1182\/blood-2025-4543","DOI":"10.1182\/blood-2025-4543"},{"issue":"6","key":"8406_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2169\/internalmedicine.50.4636","volume":"50","author":"Y Matsuyama","year":"2011","unstructured":"Matsuyama Y, Nagashima T, Honne K et al (2011) Successful treatment of a patient with rheumatoid arthritis and IgA-\u03ba multiple myeloma with tocilizumab. Int Med (Tokyo, Japan) 50(6):639\u2013642. https:\/\/doi.org\/10.2169\/internalmedicine.50.4636","journal-title":"Int Med (Tokyo, Japan)"},{"key":"8406_CR26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.174482","author":"C Lam","year":"2018","unstructured":"Lam C, Ferguson ID, Mariano MC (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment[J]. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2017.174482","journal-title":"Haematologica"},{"issue":"7","key":"8406_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","volume":"12","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Carubbi F, Liakouli V et al (2013) Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy[J]. Autoimmun Rev 12(7):709\u2013716. https:\/\/doi.org\/10.1016\/j.autrev.2012.10.004","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8406_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s002960050120","volume":"19","author":"S Hirohata","year":"2000","unstructured":"Hirohata S, Yanagida T, Nakamura H et al (2000) Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals[J]. Rheumatol Int 19(4):153\u2013159. https:\/\/doi.org\/10.1007\/s002960050120","journal-title":"Rheumatol Int"},{"key":"8406_CR29","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.intimp.2021.108078","volume":"99","author":"A Singh","year":"2021","unstructured":"Singh A, Behl T, Sehgal A et al (2021) Mechanistic insights into the role of B cells in rheumatoid arthritis[J]. Int Immunopharmacol 99:108078. https:\/\/doi.org\/10.1016\/j.intimp.2021.108078","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"8406_CR30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/ard-2023-224092","volume":"83","author":"MH Hoffmann","year":"2024","unstructured":"Hoffmann MH, Kirchner H, Kr\u00f6nke G et al (2024) Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseases. Ann Rheum Dis 83(10):1233\u20131253. https:\/\/doi.org\/10.1136\/ard-2023-224092","journal-title":"Ann Rheum Dis"},{"key":"8406_CR31","doi-asserted-by":"publisher","first-page":"102555","DOI":"10.1016\/j.coi.2025.102555","volume":"94","author":"CS Savvides","year":"2025","unstructured":"Savvides CS, James EA, Buckner JH (2025) Rheumatoid arthritis - the role of T cells in thiscomplex systemic autoimmune disease[J]. Curr Opin Immunol 94:102555. https:\/\/doi.org\/10.1016\/j.coi.2025.102555","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"8406_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.17219\/acem\/73720","volume":"27","author":"H Abdelmawgoud","year":"2018","unstructured":"Abdelmawgoud H, Saleh A (2018) Anti-inflammatory and antioxidant effects of mesenchymal andhematopoietic stem cells in a rheumatoid arthritis rat model. Adv Clin Exp Med 27(7):873\u2013880. https:\/\/doi.org\/10.17219\/acem\/73720","journal-title":"Adv Clin Exp Med"},{"key":"8406_CR33","doi-asserted-by":"publisher","first-page":"756029","DOI":"10.3389\/fmed.2021.756029","volume":"8","author":"AE El-Kadiry","year":"2021","unstructured":"El-Kadiry AE, Rafei M, Shammaa R (2021) Cell Therapy: types, regulation, and clinical benefits[J]. Front Med 8:756029. https:\/\/doi.org\/10.3389\/fmed.2021.756029","journal-title":"Front Med"},{"issue":"9074","key":"8406_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0140-6736(05)63388-0","volume":"350","author":"DJ Joske","year":"1997","unstructured":"Joske DJ, Ma DT, Langlands DR et al (1997) Autologous bone-marrow transplantation for rheumatoid arthritis[J]. Lancet (London, England) 350(9074):337\u2013338. https:\/\/doi.org\/10.1016\/s0140-6736(05)63388-0","journal-title":"Lancet (London, England)"},{"issue":"6","key":"8406_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4331\/wjbc.v12.i6.114","volume":"12","author":"S Muthu","year":"2021","unstructured":"Muthu S, Jeyaraman M, Ranjan R (2021) Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: a systematic review with meta-analysis[J]. World J Biol Chem 12(6):114\u2013130. https:\/\/doi.org\/10.4331\/wjbc.v12.i6.114","journal-title":"World J Biol Chem"},{"issue":"3","key":"8406_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jbspin.2003.10.011","volume":"31","author":"JA Snowden","year":"2004","unstructured":"Snowden JA, Passweg J, Moore JJ et al (2004) Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR[J]. J Rheumatol 31(3):482\u2013488. https:\/\/doi.org\/10.1016\/j.jbspin.2003.10.011","journal-title":"J Rheumatol"},{"issue":"1","key":"8406_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1703081","volume":"28","author":"RK Burt","year":"2001","unstructured":"Burt RK, Fassas A, Snowden J et al (2001) Collection of hematopoietic stem cells from patients with autoimmune diseases[J]. Bone Marrow Transplant 28(1):1\u201312. https:\/\/doi.org\/10.1038\/sj.bmt.1703081","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"8406_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3324\/haematol.2009.013458","volume":"95","author":"D Farge","year":"2010","unstructured":"Farge D, Labopin M, Tyndall A et al (2010) Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European group for blood and marrow transplantation working party on autoimmune diseases[J]. Haematologica 95(2):284\u2013292. https:\/\/doi.org\/10.3324\/haematol.2009.013458","journal-title":"Haematologica"},{"issue":"12","key":"8406_CR39","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41409-025-02715-x","volume":"60","author":"R Greco","year":"2025","unstructured":"Greco R, Saccardi R, Ponzano M et al (2025) BEAM\/ATG or cyclophosphamide\/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party[J]. Bone Marrow Transplant 60(12):1628\u20131634. https:\/\/doi.org\/10.1038\/s41409-025-02715-x","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"8406_CR40","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/art.10495","volume":"46","author":"J Moore","year":"2002","unstructured":"Moore J, Brooks P, Milliken S et al (2002) A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 46(9):2301\u20132309. https:\/\/doi.org\/10.1002\/art.10495","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8406_CR41","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/art.21219","volume":"52","author":"YKO Teng","year":"2005","unstructured":"Teng YKO, Verburg RJ, Sont JK et al (2005) Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 52(8):2272\u20132276. https:\/\/doi.org\/10.1002\/art.21219","journal-title":"Arthritis Rheum"},{"key":"8406_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1012868","volume":"13","author":"Z Shuai","year":"2022","unstructured":"Shuai Z, Zheng S, Wang K et al (2022) Reestablish immune tolerance in rheumatoid arthritis. Front Immunol 13:1012868. https:\/\/doi.org\/10.3389\/fimmu.2022.1012868","journal-title":"Front Immunol"},{"issue":"1","key":"8406_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5500\/wjt.v6.i1.199","volume":"6","author":"S Ramaswamy","year":"2016","unstructured":"Ramaswamy S, Jain S, Ravindran V (2016) Hematopoietic stem cell transplantation for auto immune rheumatic diseases[J]. World J Transpl 6(1):199\u2013205. https:\/\/doi.org\/10.5500\/wjt.v6.i1.199","journal-title":"World J Transpl"},{"key":"8406_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-026-02983-1","author":"K Kirgizov","year":"2026","unstructured":"Kirgizov K, Greco R, Badoglio M et al (2026) Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplant. https:\/\/doi.org\/10.1038\/s41409-026-02983-1","journal-title":"Bone Marrow Transplant"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08406-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:41Z","timestamp":1793423141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08406-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8406"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08406-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was approved by the Institutional Review Board of Luoyang Central Hospital (LWLL-2026\u201305-26\u201302). Written informed consent was obtained from the patient for publication of this report and any related clinical data. The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}